Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
48.77
-0.68 (-1.38%)
At close: Jun 30, 2025, 3:59 PM
49.41
1.32%
After-hours: Jun 30, 2025, 05:53 PM EDT
-1.38% (1D)
| Bid | 49.41 |
| Market Cap | 632.47M |
| Revenue (ttm) | 302K |
| Net Income (ttm) | -180.73M |
| EPS (ttm) | -26.68 |
| PE Ratio (ttm) | -1.83 |
| Forward PE | -6.26 |
| Analyst | Strong Buy |
| Ask | 51 |
| Volume | 856,368 |
| Avg. Volume (20D) | 476,067 |
| Open | 48.31 |
| Previous Close | 49.45 |
| Day's Range | 46.18 - 50.48 |
| 52-Week Range | 10.14 - 56.83 |
| Beta | 0.80 |
About CDTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CDTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CDTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+113.84%
Cidara Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago
+15.41%
Cidara Therapeutics shares are trading higher. The company announced a $105 million private placement.
1 month ago · seekingalpha.com
Cidara Therapeutics, Inc. (CDTX) Q1 2025 Earnings Call TranscriptCidara Therapeutics, Inc. (NASDAQ:CDTX ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Brian Ritchie - LifeSci Advisors Jeffrey Stein - President and Chief Executive Off...
